HN
Harshad Nanubhai Rathod
About Harshad Nanubhai Rathod
Data last updated:
Harshad Nanubhai Rathod is a Director at Accretion Pharmaceuticals Limited (since 2023), Director at Accretion Nutraveda Limited (since 2021) and Director at Accretion Nutraveda Limited (since 2021). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹89.49 Cr; the largest is Accretion Pharmaceuticals Limited at ₹57.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Accretion Pharmaceuticals Limited L21004GJ2023PLC146545 | Director | 29 Nov 2023 | 2023 | ₹57.47 Cr (FY 2025) | Active |
 Accretion Nutraveda Limited U24290GJ2021PLC121216 | Director | 16 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
| Accretion Nutraveda Limited L24290GJ2021PLC121216 | Director | 16 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
Board colleagues of Harshad Nanubhai Rathod
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harshad Nanubhai Rathod
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harshad Nanubhai Rathod
Harshad Nanubhai Rathod currently holds 3 directorships: Accretion Pharmaceuticals Limited (Director, since 29 Nov 2023, revenue ₹57.47 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 16 Mar 2021, revenue ₹16.01 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 16 Mar 2021, revenue ₹16.01 Cr (FY 2025)).
Harshad Nanubhai Rathod was first appointed on 16 Mar 2021 as Director at Accretion Nutraveda Limited. The most recent appointment on record is 29 Nov 2023 at Accretion Pharmaceuticals Limited.
The 3 current companies of Harshad Nanubhai Rathod that report revenue have a combined latest revenue of ₹89.49 Cr: Accretion Pharmaceuticals Limited ₹57.47 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025).
The current boards of Harshad Nanubhai Rathod's companies include Chand Rameshbhai Kanabar (Accretion Pharmaceuticals Limited), Grishma A Shewale (Accretion Pharmaceuticals Limited), Hardik Mukundbhai Prajapati (Accretion Pharmaceuticals Limited), Mayur Popatlal Sojitra (Accretion Pharmaceuticals Limited), Nishtha Harivanshi Pamnani (Accretion Pharmaceuticals Limited), Roshni Dharmendrabhai Shah (Accretion Pharmaceuticals Limited), among others.